메뉴 건너뛰기




Volumn 28, Issue 10, 2008, Pages 1031-1034

Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 4 years

Author keywords

Efficacy; Etanercept; Safety; Young children

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; THALIDOMIDE;

EID: 47249145977     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0563-2     Document Type: Article
Times cited : (27)

References (14)
  • 1
    • 0012603018 scopus 로고
    • Epidemiology of juvenile rheumatoid arthritis
    • Petty R, Malleson P (1987) Epidemiology of juvenile rheumatoid arthritis. World Pediatr Child Care 3:205-210
    • (1987) World Pediatr Child Care , vol.3 , pp. 205-210
    • Petty, R.1    Malleson, P.2
  • 3
    • 0026465619 scopus 로고
    • Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis
    • Wallace CA, Sherry DD (1992) Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. J Rheum 19:1604-1607
    • (1992) J Rheum , vol.19 , pp. 1604-1607
    • Wallace, C.A.1    Sherry, D.D.2
  • 6
    • 0033611472 scopus 로고    scopus 로고
    • A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
    • Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259
    • (1999) N Engl J Med , vol.340 , pp. 253-259
    • Weinblatt, M.E.1    Kremer, J.M.2    Bankhurst, A.D.3    Bulpitt, K.J.4    Fleischmann, R.M.5    Fox, R.I.6
  • 8
    • 0034729950 scopus 로고    scopus 로고
    • Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial
    • Mease PJ, Goffe BS, Metz J, Vandersoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356:385-390
    • (2000) Lancet , vol.356 , pp. 385-390
    • Mease, P.J.1    Goffe, B.S.2    Metz, J.3    Vandersoep, A.4    Finck, B.5    Burge, D.J.6
  • 9
    • 0034673697 scopus 로고    scopus 로고
    • Etanercept in children with polyarticular juvenile rheumatoid arthritis
    • Pediatric Rheumatology Collaborative Study Group et al.
    • Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ et al; for Pediatric Rheumatology Collaborative Study Group (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:763-769
    • (2000) N Engl J Med , vol.342 , pp. 763-769
    • Lovell, D.J.1    Giannini, E.H.2    Reiff, A.3    Cawkwell, G.D.4    Silverman, E.D.5    Nocton, J.J.6
  • 10
    • 0037231476 scopus 로고    scopus 로고
    • Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial
    • Pediatric Rheumatology Collaborative Study Group et al.
    • Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC et al; for Pediatric Rheumatology Collaborative Study Group (2003) Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 48:218-226
    • (2003) Arthritis Rheum , vol.48 , pp. 218-226
    • Lovell, D.J.1    Giannini, E.H.2    Reiff, A.3    Jones, O.Y.4    Schneider, R.5    Olson, J.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.